酸化和激活Jak-3 Janus 激酶,以应对双白素-2的作用
J A Johnston1, M Kawamura, R A Kirken
1Leukocyte Cell Biology Section, PRI/DynCorp, Frederick, Maryland.
Nature
|July 14, 1994
概括
互白素-2 (IL-2) 通过它的受体 (IL-2R) 激活免疫细胞. 这项研究确定了Janus激酶3 (Jak-3) 作为与T细胞和自然杀手细胞中的IL-2R结合的关键信号分子.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞信号传递 细胞信号传递
- 分子生物学分子生物学
背景情况:
- 互白素-2 (IL-2) 是免疫反应的关键细胞因子,作为T细胞的自生长因子,并激活B细胞和自然杀手 (NK) 细胞.
- IL-2受体 (IL-2R) 信号传递涉及蛋白质氨酸酸化,SRC家族激酶如Lck是已知的激活剂.
- IL-2信号传递可以独立于Lck发生,这表明其他蛋白质氨酸激酶的参与.
研究的目的:
- 为了识别参与互乐金-2受体 (IL-2R) 信号传递的新型蛋白质氨酸激酶.
- 调查Janus激酶家族在IL-2R信号转导中的作用.
主要方法:
- 研究了Janus激酶3 (Jak-3) 与IL-2R复合物的相关性.
- 利用人类外周血液T细胞和自然杀手细胞进行实验分析.
主要成果:
- 确定了Janus激酶家族的新成员Jak-3,与IL-2R结合在一起.
- 证明Jak-3与人类T细胞和NK细胞中的IL-2R相关.
结论:
- 简氏激酶3 (Jak-3) 是互乐金-2受体 (IL-2R) 途径的关键信号组成部分.
- 杰克-3在人类T细胞和自然杀伤细胞的IL-2信号传递中发挥着重要作用,可能独立于Lck.
相关概念视频
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...


